FDA committee recommends approval for “female Viagra”

An advisory committee of the US Food and Drug Administration voted 18 to six, on 4 June, to recommend approval of flibanserin, for the treatment of premenopausal women with hypoactive sexual desire. It is the third time that the FDA has considered the pink pill that is hoped to be the women’s ver...